Kathryn L. Ackley, Ph.D., Vice President, Business Development and Project Management, Girindus, USA
Dr. Hüseyin Aygün, CSO, Nucleic Acid Technologies, BioSpring GmbH, Germany
Bob D. Brown, Ph.D., Chief Scientific Officer and Senior Vice President, Research, Dicerna Pharmaceuticals, USA
José de Chastonay, Ph.D., Chief Marketing Officer, Bachem Holding AG, Switzerland
Jesse Z. Dong, Ph.D., Vice President, Compound Discovery, Ipsen, USA
Takefumi Gemba, Ph.D., Executive Director of the Board, Strategic Drug Discovery, Chiralgen; Executive Officer, Translational Research, SNBL, Ltd., Japan
Robert Hagopian, Director, Business Development, PolyPeptide Laboratories, USA
Peter Hoffmann, Ph.D.
Christopher P. Holmes, Ph.D., Executive Director, Chemistry, Affymax, Inc., USA
Shinya Ihara, Director, Pharmaceutical Research, R&D, Anges MG, Inc., Japan
Jesper Lau, Ph.D., Vice President, Diabetes Protein and Peptide Chemistry, Novo Nordisk, Denmark
Dong-ki Lee, Ph.D., Associate Professor, Chemistry, Sungkyunkwan University; Founder, BioMolecular Therapeutics, Inc., South Korea
Shawn Lee, Ph.D., President and CEO, CPC Scientific, USA and China
Paula Lorence, Vice President, Business Development, Avecia, USA
Patrick Y. Lu, Ph.D., Founder, President and CEO, Sirnaomics, Inc., USA and China
Bruce Morimoto, Ph.D., Vice President, Drug Development, Allon Therapeutics, Inc., Canada
Takahiro Nakazawa, Ph.D., Senior Director, Research and Development, Anges MG, Inc., Japan
Lubomir V. Nechev, Ph.D., Vice President, Process Chemistry, Alnylam Pharmaceuticals, Inc., USA
El Djouhar Rekai, Upstream Process Group Leader, Lonza Braine SA, Belgium
Dmitry Samarsky, Ph.D., Executive Vice President, Technology Development, RiboBio, China
Hideaki Sato, General Manager, Technical Support & Marketing Division, GeneDesign, Inc., Japan
G. Susan Srivatsa, Ph.D., President, ElixinPharma, USA
Hiroaki Suga, Ph.D., Professor, Chemistry, School of Science, The University of Tokyo, Japan; PeptiDream Inc., Japan
Daisuke Takahashi, Section Chief, Research Institute for Bioscience products and Fine Chemicals, Ajinomoto Co., Inc., Japan
James D. Thompson, Ph.D., Vice President, Pharmaceutical Development, Quark Pharmaceuticals, Inc., USA
Blake Unterreiner, Business Development Manager, Nucleic Acid Solutions Division, Agilent Technologies, Inc., USA
